Journal of the American Society of Nephrology, Vol 2, 1201-1207, Copyright © 1992 by American Society of Nephrology

REGULAR ARTICLES

Tubular resistance to furosemide contributes to the attenuated diuretic response in nephrotic rats

KA Kirchner, JR Voelker and DC Brater
Department of Medicine, University of Mississippi Medical Center, Jackson 39216-4505.

A blunted response to loop diuretics frequently occurs in nephrotic syndrome (NS). Observations that nephrotic humans have reduced sodium excretion at normal rates of diuretic excretion have suggested that tubular resistance to the drug may contribute to diuretic resistance. To determine if tubular resistance to furosemide exists in NS, late proximal and early distal tubular micropuncture was performed in rats with puromycin aminonucleoside-induced NS and in control rats after an i.v. bolus dose of furosemide of 1 mg/kg body wt. Absolute and fractional urinary sodium excretions were less (P less than 0.05) in NS rats than in control rats after furosemide. Inulin clearance and total urinary furosemide excretion, however, were not different between groups. Thus, similar to reports in humans, the urinary sodium-to- furosemide excretion ratio was less (P less than 0.05) in NS than in control rats. Single-nephron GFR and chloride delivery to late proximal sites were not different between groups after furosemide. In contrast, absolute and fractional chloride deliveries to early distal sites were less (P less than 0.05) in NS rats after furosemide. Calculated loop chloride reabsorption after furosemide was greater (P less than 0.05) in NS than in control rats when expressed either as percentage of filtered load (39.4 +/- 3.1 versus 28.2 +/- 2.0%) or delivered load (67.9 +/- 4.7 versus 48.3 +/- 3.0%). Loop fluid reabsorption was not different between groups. Thus, loop chloride reabsorption is inhibited to a lesser extent by i.v. furosemide in NS than in normal rats.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				N. Takamura, T. Maruyama, E. Chosa, K. Kawai, Y. Tsutsumi, Y. Uryu, K. Yamasaki, T. Deguchi, and M. Otagiri BUCOLOME, A POTENT BINDING INHIBITOR FOR FUROSEMIDE, ALTERS THE PHARMACOKINETICS AND DIURETIC EFFECT OF FUROSEMIDE: POTENTIAL FOR USE OF BUCOLOME TO RESTORE DIURETIC RESPONSE IN NEPHROTIC SYNDROME Drug Metab. Dispos., April 1, 2005; 33(4): 596 - 602. [Abstract] [Full Text] [PDF]

				S. S. Shankar and D. C. Brater Loop diuretics: from the Na-K-2Cl transporter to clinical use Am J Physiol Renal Physiol, January 1, 2003; 284(1): F11 - F21. [Abstract] [Full Text] [PDF]

				G. DESCHÊNES, M. WITTNER, A. D. STEFANO, S. JOUNIER, and A. DOUCET Collecting Duct Is a Site of Sodium Retention in PAN Nephrosis: A Rationale for Amiloride Therapy J. Am. Soc. Nephrol., March 1, 2001; 12(3): 598 - 601. [Abstract] [Full Text]

				R. AGARWAL, J. C. GORSKI, K. SUNDBLAD, and D. C. BRATER Urinary Protein Binding Does Not Affect Response to Furosemide in Patients with Nephrotic Syndrome J. Am. Soc. Nephrol., June 1, 2000; 11(6): 1100 - 1105. [Abstract] [Full Text]

				D. C. Brater Diuretic Therapy N. Engl. J. Med., August 6, 1998; 339(6): 387 - 395. [Full Text] [PDF]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673